In GBM models, curcumin analogues reverse temozolomide resistance via ubiquitination‐mediated degradation of the androgen receptor, subsequently inhibiting GPX4 activity and inducing ferroptosis [668]. The gene discussed is GPX4; the disease is glioblastoma.